💔🇵🇸 This doctor performs an amputation on his 16-year-old daughter’s leg, without surgery, on the dining table, in his house surrounded by tanks, just minutes away from Al-Shifa Hospital in Gaza.
@mndresearch#Support ALS patients worldwide
#Support ALS patients in Egypt
We want to get us into clinical trials of the disease in Egypt and the Arab world
So far, 10 aftershocks of M 5.5 and larger have occurred in #Turkey (following the initial Mw 7.8). Aftershocks will continue in the coming days and possibly weeks. A stronger aftershock approaching/exceeding M 6 is possible. #earthquake#deprem.
@US_FDA I am sure there is a cure for amyotrophic lateral sclerosis but the question is when do you sympathize and when is the final treatment for this disease approved??!#andALS
Thank you to Dr Billy Dunn of @CDER for his leadership & for committing to exercise the "broadest of regulatory flexibility" for diseases with critical unmet needs like #ALS.
https://t.co/budHnTxq1u
#Relyvrio#MND#clinicaltrials
We applaud the FDA’s approval of AMX0035 (RELYVRIO™) for treatment of #ALS. This is more than a step forward – it is momentum, and it must continue.
Read our full response: https://t.co/dzJDF8JV9O
“This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Office of Neuroscience in FDA’s Center for Drug Evaluation and Research.
Today, we approved a drug to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. https://t.co/sMPm1pOvEb